Mark Lappe stock trades
Chief Executive Officer of Inhibrx Biosciences
10 open-market trades reported in the last 3 months: 10 buys for $3.6M. All 10 were held indirectly, as filed (through a trust, a fund, or another account). The newest was filed Sep 28.
Where Mark Lappe files
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 3 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 10 |
Mark Lappe's trades, as filed
Open-market buys and sales, newest first, each with its Form 4 on the SEC's site. A Plan tag marks a sale under a trading plan set up in advance.
| Stock | Traded |
|---|---|
| Sep 28SEC filing | |
| Sep 28SEC filing | |
| Sep 25SEC filing |
7 more trades on record. Pro members see every trade, the shares Mark Lappe held after each, and every filing.
Get in free →We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.